| Dr David Alan Strauch, PD | |
|
200 N Ohio St, Appleton City, MO 64724-1148 | |
| (660) 679-1592 | |
| (660) 476-5563 |
| Full Name | Dr David Alan Strauch |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 200 N Ohio St, Appleton City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417980301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 41872 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Alan Strauch, PD 200 N Ohio St, Appleton City, MO 64724-1148 Ph: (660) 679-1592 | Dr David Alan Strauch, PD 200 N Ohio St, Appleton City, MO 64724-1148 Ph: (660) 679-1592 |
News Archive
Janssen-Cilag International NV today announced the early stopping of PCYC-1112-CA, the Phase 3 study of ibrutinib in the treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, based on the recommendation of an Independent Data Monitoring Committee, which concluded that the study showed a significant difference in progression-free survival as compared to the control, the primary endpoint of the study.
"The lives of more than 740,000 people in nine African countries were saved between 2004 and 2008 by the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]," according to a study conducted by Stanford University School of Medicine researchers and published in the Journal of the American Medical Association (JAMA) on Wednesday, HealthDay News reports.
If a pregnant woman with high blood pressure and no history of headache suddenly develops a headache that quickly gets worse, she could be at risk for pregnancy complications, including preeclampsia, which put both the mother and fetus at risk.
China Medical Technologies, Inc. (the "Company"), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company will hold its annual general meeting of shareholders at the Company's office at 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, the People's Republic of China on November 16, 2009 at 9:00 a.m., local time.
Non-alcoholic fatty liver disease, which may soon be the leading indication for liver transplant, is found to be significantly associated with worse transplant outcomes. In addition, a new tool for diagnosing NAFLD represents an alternative to liver biopsy, which is more expensive and prone to complications, and ultrasound and alfafeprotein blood test screening are an effective alternative to CT scan and MRI for patients with cirrhosis at high risk for hepatocellular cancer.
› Verified 6 days ago
Darrell D Anstine, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 121 W 4th St, Appleton City, MO 64724 Phone: 660-476-2142 Fax: 660-476-5563 |